Send to a Friend Font Size: Increase Decrease

AKBA and QTTB Related Headlines

Dec 1, 2025 07:07AM Q32 Bio sells complement inhibitor ADX-097 to Akebia for $12 million
Dec 1, 2025 07:00AM Akebia Announces Establishment of Rare Kidney Disease Pipeline
Dec 1, 2025 07:00AM Q32 Bio Sells Complement Inhibitor ADX-097

AKBA and QTTB Related Press Releases

Dec 1, 2025 07:00AM Akebia Announces Establishment of Rare Kidney Disease Pipeline
Dec 1, 2025 07:00AM Q32 Bio Sells Complement Inhibitor ADX-097

AKBA and QTTB Related SEC Filings